GLI1 and cancer: Since GLI1 is canonically active in embryonic development, with minimal basal expression in differentiated cells, it 1) serves as a biomarker for de-differentiation in cancer cells, particularly those refractory to treatment and 2) provides a prominent target not readily expressed in most non-cancerous tissue.